Spotlight on Alveolar soft part sarcoma – NCI

National Cancer Institute (NCI) shared a post on LinkedIn:

“Alveolar soft part sarcoma (ASPS) is a rare, slow-growing cancer that starts in soft tissues and affects mostly adolescents and young adults. ASPS does not respond to chemotherapy, and when patients’ tumors cannot be removed surgically, it has been difficult to treat.

Many patients with ASPS are referred to the NIH Clinical Center (CC), where a clinical trial led to the first FDA-approved treatment of the drug atezolizumab for advanced cases of the cancer. Read more.”

Source: NCI/LinkedIn